Life Sciences team attended inspiring evening symposium organised by the Center for Personalized Cancer Treatment
Last Monday several members of our Life Sciences team attended an evening symposium organised by the Center for Personalized Cancer Treatment (CPCT).
CPCT is conducting research to identify the most effective treatments for cancer patients while minimizing the side effects. CPCT aims to offer every cancer patient personalized and tailor made treatment, based on the genetic properties of the patient’s tumor.
The evening was about meeting with CPCT and the research conducted by CPCT. It was a very interesting and informative symposium where we learned more about the CPCT-02 study, the DRUP study, Hartwig Medical Foundation, Barcode for life and the chance of finding unexpected results by sequencing of DNA.
To properly interpret the sequencing results of a tumor, DNA of the tumor must be compared to the DNA of healthy tissue (blood) from the patient. Mutations which may indicate an increased risk for certain conditions or diseases in the family may be found by chance. Participating patients are provided with the choice whether or not to receive information about several categories of such indications.
We thank CPCT and all speakers for an inspiring evening!
Should you have any questions regarding the above, please do not hesitate to contact Jacobine van Beijeren or your regular Loyens & Loeff advisor.
Follow our Showcase Page on LinkedIn for updates and more Life Sciences Bits.